(Q43781475)

26 November 2017

title

Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake in elderly patients with diabetes (English)

1 reference

26 November 2017

4

J F Habener

1 reference

26 November 2017

G S Meneilly

1

1 reference

26 November 2017

C H McIntosh

2

1 reference

26 November 2017

R A Pederson

3

1 reference

26 November 2017

R Gingerich

5

1 reference

26 November 2017

J M Egan

6

1 reference

26 November 2017

D Elahi

7

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

The Journals of Gerontology

26 November 2017

published in

1 reference

26 November 2017

volume

56

1 reference

26 November 2017

issue

11

1 reference

26 November 2017

page(s)

M681-5

1 reference

Glucagon-like peptide-1 7-36: a physiological incretin in man.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F56.11.M681

Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F56.11.M681

The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F56.11.M681

Glucagon-like peptide 1: a potent glycogenic hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F56.11.M681

Extrapancreatic action of truncated glucagon-like peptide-I in Otsuka Long-Evans Tokushima Fatty rats, an animal model for non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F56.11.M681

Effects of glucagon-like peptide 1 on the kinetics of glycogen synthase a in hepatocytes from normal and diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F56.11.M681

Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F56.11.M681

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F56.11.M681

Insulinotropic hormone glucagon-like peptide-1-(7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F56.11.M681

Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F56.11.M681

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F56.11.M681

Effect of aging and diabetes on the enteroinsular axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F56.11.M681

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F56.11.M681

Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F56.11.M681

Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F56.11.M681

10.1093/GERONA/56.11.M681

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference